24 February 2014 - Deborah Wilkes
Archived
Moberg Pharma is seeking further acquisitions and in-licensing opportunities, according to chief executive officer Peter Wolpert, and is particularly keen to follow up its purchase of three established brands from Bayer HealthCare with more deals involving non-prescription products for the US market.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.